Evidence map›Paper›PMID 35245101›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.

Jeffrey C Buchsbaum, Michael G Espey, Ceferino Obcemea, Jacek Capala, Mansoor Ahmed, Pataje G Prasanna, Bhadrasain Vikram, Julie A Hong, Beverly Teicher, Molykutty J Aryankalayil and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Radioresistance Mechanisms in Head and Neck Cancer.Clinical and experimental otorhinolaryngology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeffrey C BuchsbaumNational Cancer Institute, Bethesda, MD.ORCID 0000-0002-8695-3448
Michael G EspeyNational Cancer Institute, Bethesda, MD.
Ceferino ObcemeaNational Cancer Institute, Bethesda, MD.
Jacek CapalaNational Cancer Institute, Bethesda, MD.
Mansoor AhmedNational Cancer Institute, Bethesda, MD.
Pataje G PrasannaNational Cancer Institute, Bethesda, MD.
Bhadrasain VikramNational Cancer Institute, Bethesda, MD.
Julie A HongNational Cancer Institute, Bethesda, MD.ORCID 0000-0003-4207-6364
Beverly TeicherNational Cancer Institute, Bethesda, MD.ORCID 0000-0003-1535-7304
Molykutty J AryankalayilNational Cancer Institute, Bethesda, MD.
Michelle A BylickyNational Cancer Institute, Bethesda, MD.ORCID 0000-0001-6237-9106
C Norman ColemanNational Cancer Institute, Bethesda, MD.ORCID 0000-0003-3121-1663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsHumansNational Cancer Institute (U.S.)United States

Identifiers

PMID35245101
PMCPMC9177246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.